[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100629180":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":52,"collaborators":56,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":26,"enrollmentInfo":69,"targetDuration":26,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":86,"whyStopped":26,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Kuopio University Hospital","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"EMDR + TAU (Immediate EMDR)","EXPERIMENTAL","Participants receive eye movement desensitization and reprocessing (EMDR) therapy in addition to treatment as usual during the first treatment period. PTSD symptoms are assessed at baseline (T1), after the first treatment period (T2), and after the second treatment period (T3).",[13,14],"Behavioral: Eye Movement Desensitization and Reprocessing (EMDR)","Other: treatment as usual (TAU) (Control Group)",{"label":16,"type":17,"description":18,"interventionNames":19},"TAU + EMDR (Delayed EMDR)","ACTIVE_COMPARATOR","Participants receive treatment as usual during the first treatment period. After the first assessment (T2), participants receive EMDR therapy during the second treatment period. PTSD symptoms are assessed at baseline (T1), after the first treatment period (T2), and after the second treatment period (T3).",[13,14],[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","Eye Movement Desensitization and Reprocessing (EMDR)","Eye movement desensitization and reprocessing (EMDR) therapy delivered by trained therapist according to standard EMDR procedures for the treatment of post-traumatic stress disorder.",[9,16],null,{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"treatment as usual (TAU) (Control Group)","Treatment as usual refers to the standard care normally available to patients with PTSD in the participating clinical setting. This may include routine clinical follow-up and other supportive care provided according to usual practice.",[9,16],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Ulla Sankilampi, Professor","CONTACT","+358447172464","ulla.sankilampi@kuh.fi",[38],{"facility":5,"status":26,"city":39,"state":26,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Kuopio","70211","Finland","FI",{"type":44,"coordinates":45},"Point",[46,47],27.67703,62.89238,{"lat":47,"lon":46},[50],{"name":51,"role":34,"phone":35,"phoneExt":26,"email":36},"Ulla Sankilampi, professor",{"type":53,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Ulla Sankilampi","Head of the Neonatal Intensive Care Unit",[57],{"name":58,"class":6},"University of Eastern Finland","100629180","parental-emdr-therapy-after-a-babys-stay-in-the-nicu-100629180",false,"NCT07471321","Parental EMDR Therapy After a Baby's Stay in the NICU","Effectiveness of an EMDR Intervention in Reducing Trauma-Related Symptoms Among Parents Following Their Infant's Birth and Neonatal Intensive Care: A Randomized Controlled Trial","EMDR-NICU","Inclusion Criteria:\n\n* Adults aged 18 years or older\n* Presence of post-traumatic stress symptoms\n* Eligible to receive EMDR therapy according to clinical assessment\n* Ability to understand study procedures and provide informed consent\n* Sufficient proficiency in the Finnish language to complete study assessments and participate in therapy\n\nExclusion Criteria:\n\n* Acute psychiatric condition requiring immediate specialized treatment (e.g., acute psychosis or severe suicidal crisis).\n* Severe cognitive impairment or neurological condition that would prevent participation in psychotherapy or completion of study assessments.\n* Ongoing trauma-focused psychotherapy at the time of enrollment.\n* Any condition judged by the investigator to interfere with safe participation in the study.","ALL","18 Years",{"count":70,"type":71},80,"ESTIMATED","INTERVENTIONAL",[74],"NA","This randomized clinical trial evaluates the effectiveness of eye movement desensitization and reprocessing (EMDR) therapy in reducing symptoms of post-traumatic stress disorder (PTSD). Participants with PTSD symptoms will be randomly assigned in a 1:1 ratio to either immediate EMDR in addition to treatment as usual (EMDR+TAU) or delayed EMDR following an initial treatment-as-usual period (TAU+EMDR). Randomization will be stratified by sex.\n\nPTSD symptoms will be assessed using the PTSD Checklist for DSM-5 (PCL-5) at baseline (T1), after the first treatment period (T2), and after the second treatment period (T3). The primary outcome is PTSD symptom severity measured by the PCL-5 at T2, comparing participants receiving EMDR+TAU with those receiving TAU alone during the first treatment period.\n\nSecondary outcomes include clinically meaningful improvement in PTSD symptoms, defined as a reduction of at least 10 points on the PCL-5, symptom change during the initial treatment-as-usual period, the effect of delayed EMDR, and the durability of the EMDR treatment effect over time.",[77],"Stress Disorders, Post-Traumatic",[79,80,81,82,83,84,85],"Post-Traumatic Stress Disorders","Psychological Trauma","Eye Movement Desensitization and Reprocessing","Parents","Infant, Newborn","Intensive Care Units, Neonatal","Psychotherapy, Trauma Focused","NOT_YET_RECRUITING","2026-03-12",{"date":89,"type":90},"2026-03-13","ACTUAL",{"date":92,"type":71},"2026-03",{"date":94,"type":71},"2027-08",{"name":5,"class":6},1]